trial new american journal psychiatry found adding metformin regimen atypical antipsychotic medications stopped children continuing gain weight taking atypical antipsychotics shrug concerns skyrocketing use atypical antipsychotic use among kids part accompanying editorial towbin say study address long term safety metformin treatment whether weight loss sustained important vulnerable children may require metformin treatment long continue take atypical antipsychotics typically symptoms last many years metformin relative pheformin long term side effects lead folate deficiency chronic users fatal lactic acidosis metformin seen context uncompensated congestive heart disease acute renal insufficiency liver disease may emerge chronic use nonsteroidal anti inflammatory drugs reassuring conditions relatively rare children adolescents addition study compare pharmacological treatment specific targeted treatments dietary control combine dietary counseling exercise behavioral intervention shown effective adults patients metformin trial missed doses medication behavioral programs also problems patients failing adhere diet exercise schedules occasion finally noteworthy field high proportion cohort diagnoses symptoms clear fda approved indication treatment atypical antipsychotics attentional disorders seven oppositional defiant disorder view doubtless many take blessing continue use atypicals everything including adhd oppositional defiant disorder apparently cure weight gain discovered get me wrong metformin really helpful great i await longer term studies i jump bandwagon